Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, Good to know.
There was. 250,000 shares at $.0475
https://www.nasdaq.com/symbol/rdgl/after-hours
Thank You for the link. Great find!
That is tremendous news!
I can't believe its been a year already. I remember seeing the facebook reposts here and following along. Thanks to all who reposted them, as I'm not on facebook.
Then this, a year later.
Isopet Rocks!
Tweet about Drake
Great find!
Thank You for pointing that out to me. The article I posted was from 2016. It was more for information on the process rather than the time lines. It did mention this though.
From your keyboard to the FDA's ears
Hope so! Plus they are already several years into the process.
Thank You RTF310 for clearing up my misunderstanding. After reading your reply, I found this.
What is the difference between Tier 1 versus Tier 2 offerings?
I too got tripped up by the part I highlighted
I wouldn't fixate on the prices listed in the preliminary offering circular.
From here: Bold and Color by me
1-A PART II AND III
I don't know if this was mentioned, but the Form 1-A Vivos is filing is used for the Regulation A exemption.
I tried to find something that explains what it and I found this after a little Googling.
Color and bold by me.
Thanks for the pic! Since its story time, here is my interpretation of that picture.
I believe this picture actually depicts a future Veterinarian. Perhaps she's followed Isopet treatments. She's so moved by its results, that she is dreaming of the day she too will be certified to administer Isopet. She might be pretending the cat is Drake. Notice the syringe below the bag?
"Don't worry Drake you can go home today!! One and done! All better!", she says.
She already knows one treatment of Isopet is more humane than weeks of traditional beam radiation treatments. Its possibly safer and more effective too!!
If your caption is correct, that girl is a prodigy!
Could you imagine that young girl formulating Isopet! Wow! I could barely ride bike when I was that young. Amazing! She's going places! A same day cancer treatment killing any cancer cells that came within the treatment zone. I have goosebumps! Whoa!
Vivos Inc. Summarizes the Health of Canine Therapy Patients Treated with IsoPet
I don't believe Moose had anything on his lungs to begin with. The chest x-ray is part of the follow up. If the disease were to progress it might metastasize on the lungs. Since the lungs are clear 8 months later, it seems disease progression has stopped. There also are no other sarcomas growing elsewhere or regrowing at the treated site!
Incredibly encouraging!! Amazing stuff. One day outpatient treatment. Moose was out playing while other dogs would of still had days or weeks of beam radiation treatment ahead.
This is my understanding anyway.
The dog treated on humanitarian grounds has a growth in one lung indicating the cancer may have metastasized. It will be interesting to see the results of this dogs followup.
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet
Take time to reread this post from bdvest. It was taken from Moose's Facebook page. Note the first few lines starting with 'Why do I share this?'
Thank You bdvest for posting this as some of us aren't on Facebook.
Mooses owner shared the following in facebook
This is the one I'll always remember from 2009.
vermillion
I watched this as it sank and was too scared to pull the trigger and buy it. The FDA approved their product while in bankrupcy. It was pennies, and peaked at over $30 a share over the course of several months. It did come back to earth. Today I think it trades for about a buck.
Vivos reminded me of this company when I first started buying shares. Even the way the board worked for shares in lieu of cash.
Fortunately, it seems Vivos has their financial house in order and Isopet is now on the market!
gotcha, no telling
I believe gonetopot's point was that the isotope Yttrium 90 is currently being used in people. A quick google search show's that it is.
Yttrium 90
The data is that Isopet had its first sale today. It is a real cancer treatment product. It was approved by the FDA for the treatment of solid tumors in animals.
Anything is possible, but at this point I don't believe so.
From the Feb 1, 2019 press release regarding the 1 for 8 split. Bold lettering by me
I'm not looking for a buyout at this time. I posted the PF* purchase to backup Roofus's hypothetical buyout price.
There's not much I can do about the FDA except keep my fingers crossed and believe in the process.
If the FDA denies de novo, Vivos would then do what is necessary to get approved as a class 3 device.
The FDA did grant Vivos device status in animals, so they are halfway there.
They already have revenue!!!
Radiogel was never classified as a drug. It was originally classified as a class 3 medical device.
The dogs are the clinical studies. Also data will be collected as people are being treated. Once approved as a device it can be used/administered under the guidelines for the devices classification.
This doesn't diminish safety. It is a legitimate process. It doesn't take away value.
Of course there will be testing. But they can't test in humans until approved as a device which will be either a class 2 or worst case class 3. Class 3 would require more time and testing at a cost to shareholders, hence the de novo
At least thats my understanding.
At least thats my understanding.
They are going through it now. That is what the data from the 5 dogs treated is for. The decision should be forthcoming.
That's true
Radiogel is not a drug. I don't believe there are any phase type trials for a medical device classification.
Vivos is currently gathering data for a de novo decision by the FDA, and if approved as a class 2 device, I believe they could begin treatment via trials immediately. Well, obviously after establishing proper training and followup protocols etc.
This is from their latest 10K Bold by me As per the 10K below is also covered by foward looking statements.
..............The Company believes that its submissions to the FDA to date have addressed all the FDA staff’s feedback over the past four years. Of particular importance, the Company has provided corresponding supporting data for proposed future testing of RadioGel™ to address any remaining questions raised by the FDA. We believe, although no assurances can be given, that the clinical testing modifications presented to the FDA in August 2017 will result in a de novo reclassification for RadioGel™ by the FDA....................
Here is the link to latest 10K. The regulatory history of radiogel starts on page 2, about midway down.
10-K
While I think it is good to temper expectations, PF* did just buy A**Y for $10.64 billion dollars or $48 dollars a share.
A**Y had revenue of $174 million.
A**Y had about 212 million shares outstanding and about $2 a share in cash ans short term investments($412 million)
A**Y is working on cancer drugs.
I guess they'll sell when they sell. I'm not too worried about it.
These lenders(noteholders) didn't have to convert their toxic debt to a fixed share price. After sitting down with Vivos, they could have just walked away from the table. They could have continued to sell until they made their money back, regardless of the dilution or even company solvency.
It could be. I think your number was talked about too.
That's so true! After de novo, people will be next!
At the bottom of their online application they have this:
"IsoPET® therapy price is competitive with the cost of external beam therapy."
I thought they had mentioned it was around $4,000 per treatment.
It used to be.
The Taipei Exchange (TPEx), formerly the Gre Tai Securities Market (GTSM), is the foundation dedicated to serving over-the-counter (OTC) bond trading in Taiwan.
Might be these guys now
GTSM
177.7 million shares per their press release dated June 26, 2019, Vivos Inc. Announces 1-for-8 Reverse Stock Split
Agreed, truly exciting!!
From their press release dated Jan. 09, 2019 titled Vivos Inc 2018 Highlights, Vivos listed 5 strategic objectives.
-Initiate the commercial sales of IsoPet. 1st patient identified. 1st sale coming soon.
-Secure adequate funding to expand IsoPet therapy in key regional centers. $5 million.
-Begin the pre-clinical testing for human therapy. ???FDA always a question mark???
-File for additional patent(s) to enhance our intellectual property protection. PR'ed July 2nd.
-Continue to reduce production costs to make IsoPet more affordable for the average pet owner. Possibly part of the new patents PR'ed July 2nd.
Looks like 4 down and 1 to go for the year.
I like the how they roll up their sleeves and chop away at their to do list. Congrats to Dr. Korenko and all involved! Thank You George Sharp. What an amazing story and a tremendous treatment for beloved pets.
All just my opinion
Vivos Inc. Pilot Clinic Completes Their Certification Training
BY GlobeNewswire
— 7:00 AM ET 07/09/2019
Richland WA, July 09, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (RDGL) Vivos, Inc. ( RDGLD ) is pleased to announce that Vista Veterinary Hospital has completed its first Isopet® certification training for two verterinary professionals, with more expected in the near future.
Employee certification is the last major step prior to offering public participation in our commercial IsoPet® therapy development program. We are currently finalizing the administrative details. Since Vista is the first clinic offering the Isopet® therapy, we will be screening applications using a disciplined process. We are near completion of our a web page portal for interested pet owners to submit their Expression of Interest Application. These will be reviewed by Vista. Any direct callers to Vista will be included in this same screening process. Our first patient has already been identified.
Dr. Mike Korenko stated “reaching this point is exciting. It is based on a disciplined approach, which is necessary when bringing a new cancer therapy product to market. We look forward to extending and improving the quality of life of many pets, while at the same time collecting data for our interactions with the FDA. We intend to gain experience and generate therapy data at Vista for several months before expanding to other regional clinics. All data will be shared with the veterinary oncology community.”
In addition, Dr. Charles Maitz will be formally presenting the results from the University of Missouri Isopet® developmental therapy study at the Veterinary Cancer Society Conference that is being held in October.”
I believe the D is just a flag to let investors know there has been a reverse split. I'm confident Vivos is still hard at work, and will report news as it happens.
I hope you wake up a multi millionaire today!!
Your number was closer to the common shares out
1,369,987,688/8 = 171,248,461
247 million shares if holders convert and warrent holders buy.
As of May 22, 2019, there were 1,369,987,688 shares of Common Stock outstanding.
Also up to 609,336,655 shares of convertible stock and warrants to purchase stock.
This would be a total of, assuming exercise and conversion occurred, 1,979,324,343 shares.
Post split would be about 247,415,543 assuming exercise and conversion occurred.
Bold highlight by me
From the DEFR14C dated May 22, 2019 Page 11